Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
70
BEAT Quote, Financials, Valuation and Earnings
Last price:
$2.58
Seasonality move
:
-27.11%
Day range:
$2.49 - $2.71
52-week range:
$0.54 - $4.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
219.78x
Volume:
2.7M
Avg. volume:
25.7M
1-year change:
8.37%
Market cap:
$89.2M
Revenue:
--
EPS (TTM):
-$0.66
Analysts' Opinion
-
Consensus RatingHeartBeam, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $4.63, HeartBeam, Inc. has an estimated upside of 78.57% from its current price of $2.59.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1.00 representing 100% downside risk from its current price of $2.59.
Fair Value
-
According to the consensus of 3 analysts, HeartBeam, Inc. has 78.57% upside to fair value with a price target of $4.63 per share.
BEAT vs. S&P 500
-
Over the past 5 trading days, HeartBeam, Inc. has underperformed the S&P 500 by -16.82% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
HeartBeam, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
HeartBeam, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter HeartBeam, Inc. reported revenues of --.
Earnings Growth
-
HeartBeam, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter HeartBeam, Inc. reported earnings per share of -$0.15.
Enterprise value:
87.4M
EV / Invested capital:
215.15x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.25x
EV / Free cash flow:
-5.67x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$30K
Return On Assets:
-369.57%
Net Income Margin (TTM):
--
Return On Equity:
-555.14%
Return On Invested Capital:
-555.14%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -$30K | -- | -$8K | |
| Operating Income | -$14.9M | -$19.1M | -$20.8M | -$5.1M | -$5.3M | |
| EBITDA | -$14.9M | -$19.1M | -$20.7M | -$5.1M | -$5.3M | |
| Diluted EPS | -$1.26 | -$0.69 | -$0.66 | -$0.19 | -$0.15 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $961K | $6.7M | $19.5M | $6.1M | $2.1M | |
| Total Assets | $961K | $6.7M | $19.6M | $6.7M | $2.9M | |
| Current Liabilities | $6.1M | $932K | $1M | $1.9M | $2.5M | |
| Total Liabilities | $6.1M | $932K | $1M | $1.9M | $2.5M | |
| Total Equity | -$5.2M | $5.7M | $18.6M | $4.8M | $406K | |
| Total Debt | $5.4M | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$12.2M | -$13.2M | -$15.2M | -$3.3M | -$3.2M | |
| Cash From Investing | -$144K | -$313K | -$184K | -$103K | $1.7M | |
| Cash From Financing | $25M | $105K | $11.5M | $21K | $45K | |
| Free Cash Flow | -$12.3M | -$13.5M | -$15.4M | -$3.4M | -$3.2M | |
BEAT
Sector
Market Cap
$89.2M
$28M
Price % of 52-Week High
64.75%
51.03%
Dividend Yield
0%
0%
Shareholder Yield
-20.31%
-1.54%
1-Year Price Total Return
8.37%
-17.48%
Beta (5-Year)
--
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$2.85
200-day SMA
Buy
Level
$1.56
Bollinger Bands (100)
Buy
Level
0.98 - 2.04
Chaikin Money Flow
Sell
Level
-12.5M
20-day SMA
Buy
Level
$1.68
Relative Strength Index (RSI14)
Buy
Level
59.83
ADX Line
Buy
Level
41.99
Williams %R
Neutral
Level
-42.5596
50-day SMA
Buy
Level
$1.63
MACD (12, 26)
Buy
Level
0.45
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
853.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-20.7221)
Sell
CA Score
(Annual)
Level (-7.5901)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (28.8274)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.
Stock Forecast FAQ
In the current month, BEAT has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The BEAT average analyst price target in the past 3 months is $4.63.
-
Where Will HeartBeam, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that HeartBeam, Inc. share price will rise to $4.63 per share over the next 12 months.
-
What Do Analysts Say About HeartBeam, Inc.?
Analysts are divided on their view about HeartBeam, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that HeartBeam, Inc. is a Sell and believe this share price will drop from its current level to $1.00.
-
What Is HeartBeam, Inc.'s Price Target?
The price target for HeartBeam, Inc. over the next 1-year time period is forecast to be $4.63 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is BEAT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for HeartBeam, Inc. is a Buy. 2 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of BEAT?
You can purchase shares of HeartBeam, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase HeartBeam, Inc. shares.
-
What Is The HeartBeam, Inc. Share Price Today?
HeartBeam, Inc. was last trading at $2.58 per share. This represents the most recent stock quote for HeartBeam, Inc.. Yesterday, HeartBeam, Inc. closed at $2.59 per share.
-
How To Buy HeartBeam, Inc. Stock Online?
In order to purchase HeartBeam, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get BEAT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BEAT
Sector
P/E ratio
--
23.89x
PEG ratio
-0.25x
-0.01x
P/B ratio
219.78x
1.82x
Price / LTM sales
--
1.60x
Growth Metrics
BEAT
Sector
Revenue growth
--
4.62%
Earnings growth
17.89%
10.88%
Revenue (5-year growth)
--
6.5%
Earnings forecast
--
-$0.21
Profitability
BEAT
Sector
Profitability FY 2024
-$7K
$3.5M
Return on invested capital
-555.14%
-31.77%
Return on assets
-369.57%
-27.96%
Return on equity
-555.14%
-37.63%
Earnings Date
Last Earnings Date
Nov
13
Next Earnings Date
Mar
19
Estimated Next Earnings Date
Feb
12
Balance Sheet
BEAT
Sector
Total cash
$1.9M
$26.3M
Short term investments
--
$25.7M
Total assets
$3.3M
$78M
Long term debt
--
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
